FDA Clears Wireless Maternal-Fetal Monitoring Platform
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
The expanded agreement will embed Masimo’s pulse oximetry and sensor technologies into Philips’ patient monitoring platforms to streamline clinical workflows and improve interoperability.
Epitel's REMI Vigilenz AI For Bedside Notifications has received FDA 510(k) clearance, notifying clinicians of potential seizures.
The wearable sensor system provides continuous, simultaneous monitoring of maternal and fetal vital signs to improve clinical evaluation.
Know Labs, detailed the features of the KnowU, a wearable non-invasive continuous glucose monitor that can connect to a mobile app.
Read MoreThe NIH will award up to $2 million in cash prizes to accelerate development of diagnostic and monitoring technologies for fetal health.
Read MoreAdmetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
Read MoreA study evaluated the ability of Masimo SedLine brain function monitoring to assess sedation levels during a drug-induced procedure.
Read MoreGE HealthCare announced it has received 510(k) clearance from the FDA for its Portrait Mobile wireless and wearable monitoring solution.
Read MoreA new report details how Sky Labs’ cuffless blood pressure measurement algorithm used in its CART-I BP device enables improved hypertension management and early prediction of cardiovascular events.
Read More
Royal Philips and Masimo announce U.S. FDA clearance allowing the activation of SedLine Brain Function Monitoring, Regional Oximetry (O3), and CO₂ measurements in Philips patient monitors: IntelliVue MX750 and MX850.